Previous Close | 21.28 |
Open | 21.34 |
Bid | 21.00 x 900 |
Ask | 21.20 x 800 |
Day's Range | 21.03 - 21.57 |
52 Week Range | 21.03 - 58.72 |
Volume | 4,781,028 |
Avg. Volume | 1,927,905 |
Market Cap | 3.385B |
Beta (5Y Monthly) | 0.82 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.79 |
Earnings Date | May 05, 2021 - May 10, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 29.44 |
SAN FRANCISCO, CA / ACCESSWIRE / April 16, 2021 / Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) investors with significant losses to submit your losses now.
PHILADELPHIA, PA / ACCESSWIRE / April 15, 2021 / Kaskela Law LLC announces that it is investigating Acadia Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ:ACAD) on behalf of the Company's stockholders.
NEW YORK, NY / ACCESSWIRE / April 14, 2021 / Labaton Sucharow LLP a national securities litigation firm, announces that it is investigating Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) for potential violations of the federal securities laws.